Abstract 3004: Preclinical characterization of CGT6297, a novel PI3Kα H1047R mutant-selective inhibitor
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Aaron C. Smith, Ben Arwood-Levine, Abiezer Blandon, Alexandra Born, Richard Brizendine, Payal Chatterjee, Mark J. Chicarelli, Michael L. Conner, Brad Fell, Jennifer Fulton, Anna Guarnieri, Hannah Hubert, Ravi Jalluri, Hailey Knox, Keith Koch, Daniel Krischlunas, Vijay Kumar, Sara Kuzbiel, Matt McDonald, Colin McHugh, Brent Mclean, Kelsey W. Nassar, Paul Larsen, Brad Newhouse, Scott Niman, Rob Rieger, John Robinson, Marelí Rodriguez, Leah Salituro, Vinny Scarato, Lee Stunkard, Francis Sullivan, Patrick Sutter, Roy Turton, Rob Van Gulick, Brooklynn Venteicher, Logan Vine, Shannon Winski, Shannon Winski, Hannah Work, Yeyun Zhou
Institution: Cogent Biosciences (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409627837